⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics (MLTX) Shareholders Get Answers in Latest SueWallSt Podcast
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Class Action Reminder from Pomerantz LLP for Shareholders of MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics(MLTX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
globenewswire.com
MLTX
INVESTOR ALERT: The MoonLake Immunotherapeutics Securities Fraud Class Action is Pending, Investors Urged to Contact BFA Law by December 15 Deadline
newsfilecorp.com
MLTX
MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake’s SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority
globenewswire.com
MLTX
DEADLINE ALERT for MLTX, BAX, and JHX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
globenewswire.com
MLTX
BAX
JHX
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
globenewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
MLTX
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX
prnewswire.com
MLTX